Seres Therapeutics (MCRB) Return on Assets (2015 - 2026)
Seres Therapeutics (MCRB) posted Return on Assets of 0.0% for Q1 2026, down 122.01% sequentially from 0.01% in Q2 2025, and down 1.0% YoY from 0.0% in Q1 2025.
Seres Therapeutics (MCRB) Return on Assets (2015 - 2026) Analysis & Trends
Seres Therapeutics has reported Return on Assets for 12 years, with the latest figure at 0.0% in Q1 2026.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (down 1.0% YoY) and the FY2024 annual result came in at 0.01%, changed 0.0% from the prior year.
- Return on Assets declined to 0.0% in Q1 2026 per MCRB's latest filing, from 0.01% in the prior quarter.
- Over five years, Return on Assets peaked at 0.01% in Q2 2025 and troughed at 0.7% in Q2 2022.
- A 5-year average of 0.23% and a median of 0.0% in 2026 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2022 and 2023: Return on Assets sank 69 bps in 2022, then surged 60 bps in 2023.
- Over 5 years, Return on Assets stood at 0.53% in 2022, then jumped by 100 bps to 0.0% in 2023, then soared by 769 bps to 0.01% in 2024, then rose by 15 bps to 0.01% in 2025, then plunged by 122 bps to 0.0% in 2026.
- According to Business Quant data, Return on Assets over the past three periods registered 0.0%, 0.01%, and 0.01% for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.59 Bn | 131.73 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 86.21 Bn | 78.22 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.65 Bn | 60.47 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.90 Bn | 9.51 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 0.00% |
| 10 | Seres Therapeutics | 44.36 Mn | 44.36 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Mar 31, 2026 | 0.00% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.49% |
| Mar 31, 2023 | -0.57% |
| Dec 31, 2022 | -0.53% |
| Sep 30, 2022 | -0.60% |
| Jun 30, 2022 | -0.70% |
| Mar 31, 2022 | -0.60% |
| Dec 31, 2021 | -0.53% |
| Sep 30, 2021 | -0.60% |
| Jun 30, 2021 | -0.02% |
| Mar 31, 2021 | -0.01% |